# FDA recall D-1251-2014

> **Shire Human Genetic Therapies, Inc.** · Class I · drug recall initiated 2014-03-14.

## Product

VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.

## Reason for recall

Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.

## Distribution

US Nationwide including Puerto Rico; Mexico, Columbia

## Key facts

- **Recall number:** D-1251-2014
- **Recalling firm:** Shire Human Genetic Therapies, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-03-14
- **Report date:** 2014-04-30
- **Termination date:** 2016-08-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lexington, MA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1251-2014

## Citation

> AI Analytics. FDA recall D-1251-2014. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-1251-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*